InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-30.4%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Polverino Anthony J., Directeur Scientifique. Officer active across 2 companies, notably Zymeworks Inc.. Cumulatively, 13 disclosures have been recorded. History available since 6 July 2021. The latest transaction was disclosed on 1 January 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations13 total
24,000 shares0Common StockSEC:0001104659-25-000893:0
3,882 shares0Common StockSEC:0001104659-22-011390
3,882 shares0Common StockSEC:0001104659-22-011390:0
74 shares@ US$13.940.6% of flowCommon SharesSEC:0000899243-22-001424
74 shares@ US$13.940.0000% mcap0.6% of flowCommon SharesSEC:0000899243-22-001424:0
2,000 shares0Common StockSEC:0001104659-21-151215
2,000 shares0Common StockSEC:0001104659-21-151215:0
2,216 shares0Common StockSEC:0001104659-21-148751
2,216 shares0Common StockSEC:0001104659-21-148751:0
4,900 shares@ US$15.0041.8% of flowCommon SharesSEC:0000899243-21-034985
4,900 shares@ US$15.000.0031% mcap41.8% of flowCommon SharesSEC:0000899243-21-034985:0
454 shares@ US$29.497.6% of flowCommon SharesSEC:0000899243-21-027914
454 shares@ US$29.490.0006% mcap7.6% of flowCommon SharesSEC:0000899243-21-027914:0
13 of 13 declarations
About Polverino Anthony J.
Anthony J. Polverino is the Chief Scientific Officer and Board Member at Zymeworks Inc. and Brainstorm Cell Therapeutics Inc. He is responsible for scientific leadership and innovation within both companies. With a strong background in the biopharmaceutical sector, he plays a key role in developing new therapies and products. His expertise contributes to the strategic direction of the companies.
